BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9689325)

  • 1. Apoptosis in astrocytomas with different grades of malignancy.
    Yew DT; Wang HH; Zheng DR
    Acta Neurochir (Wien); 1998; 140(4):341-7. PubMed ID: 9689325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in astrocytic neoplasms.
    Carroll RS; Zhang J; Chauncey BW; Chantziara K; Frosch MP; Black PM
    Acta Neurochir (Wien); 1997; 139(9):845-50. PubMed ID: 9351989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignancy grading of glial tumors. I. Astrocytomas].
    Martin H; Schmidt D
    Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading astrocytomas.
    Adelman LS
    Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
    Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
    Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of anaplastic changes in low-grade astrocytomas of childhood.
    Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
    Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.
    Ellison DW; Steart PV; Gatter KC; Weller RO
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):352-61. PubMed ID: 7494604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal.
    Martin S; Toquet C; Oliver L; Cartron PF; Perrin P; Meflah K; Cuillère P; Vallette FM
    J Neurooncol; 2001 Apr; 52(2):129-39. PubMed ID: 11508812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of 14-3-3 zeta sensitizes human glioblastoma cells to apoptosis induction.
    Hashemi M; Zali A; Hashemi J; Oraee-Yazdani S; Akbari A
    Apoptosis; 2018 Dec; 23(11-12):616-625. PubMed ID: 30101359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
    Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
    Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis phenomenon in the selected neoplasms of the glial origin.
    Szkudlarek M; Lebelt A; Klim B; Pawlak J; Lemancewicz D; Bogusłowicz W; Sulima D; Zimnoch L; Dziecioł J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():16-8. PubMed ID: 15638361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.
    Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG
    J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors.
    Hara A; Hirose Y; Yoshimi N; Tanaka T; Mori H
    Neurol Res; 1997 Dec; 19(6):623-8. PubMed ID: 9427964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologically confirmed changes on CT of reoperated low-grade astrocytomas.
    Afra D; Osztie E
    Neuroradiology; 1997 Nov; 39(11):804-10. PubMed ID: 9406207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
    De Witte O; Levivier M; Violon P; Brotchi J; Goldman S
    Neurosurgery; 1998 Aug; 43(2):398-9. PubMed ID: 9696102
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis.
    Holland H; Koschny T; Ahnert P; Meixensberger J; Koschny R
    Pathol Res Pract; 2010 Oct; 206(10):663-8. PubMed ID: 20570053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.
    Vlodavsky E; Soustiel JF
    J Neurooncol; 2007 Jan; 81(1):1-7. PubMed ID: 16868661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.